Lataa...
Factor XIIIa Inhibitors as Potential Novel Drugs for Venous Thromboembolism
Human factor XIIIa (FXIIIa) is a multifunctional transglutaminase with a significant role in hemostasis. FXIIIa catalyzes the last step in the coagulation process. It stabilizes the blood clot by cross-linking the α- and γ-chains of fibrin. It also protects the newly formed clot from plasmin-mediate...
Tallennettuna:
| Julkaisussa: | Eur J Med Chem |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7513741/ https://ncbi.nlm.nih.gov/pubmed/32502864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112442 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|